Microvascular Inflammation of Kidney Allografts and Clinical Outcomes.

Across 16,293 kidney-transplant biopsy specimens from 6,798 patients, the two microvascular inflammation categories newly recognized in the Banff 2022 classification identified distinct rejection phenotypes carrying a higher risk of graft loss and transplant glomerulopathy - most of them previously classed as showing no evidence of rejection.